|
Jul 30
|
MediWound reinforces wound therapy EscharEx data ahead of Phase III trial
|
|
Jul 29
|
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
|
|
May 13
|
Investors in MediWound (NASDAQ:MDWD) have seen decent returns of 65% over the past year
|
|
Apr 25
|
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
|
|
Apr 17
|
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
|
|
Mar 25
|
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
|
|
Mar 25
|
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'
|
|
Mar 24
|
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
|
|
Mar 21
|
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 21
|
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
|
|
Mar 14
|
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 7
|
Retail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as well
|
|
Mar 6
|
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
|
|
Feb 12
|
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
|
|
Jan 15
|
MediWound (MDWD)'s Technical Outlook is Bright After Key Golden Cross
|
|
Jan 9
|
Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet
|
|
Jan 9
|
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions
|
|
Jan 9
|
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
|
|
Dec 28
|
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
|
|
Dec 21
|
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
|